Swedeliver co-Director Alexandra Teleki: To a successful 2023 & prosperous 2024


As 2023 is coming to an end, SweDeliver co-Director Alexandra Teleki takes a look in the rearview mirror and identifies yet another year of many and successful Center highlights – with a crystal ball offering no less inspiring views.

Alexandra Teleki

As 2023 is coming to an end, we are pleased to share our recent highlights. In late November, SweDeliver and NextBioForm competence centers welcomed over 170 international participants from both academia and industry to snow-covered Uppsala for the New Horizons in Drug Delivery and Formulations conference. A successful gathering that provided a platform for exciting presentations and discussions, shaping the future of our field.

Our community is expanding, and we are delighted to welcome Chiesi and Recipharm as the newest additions to the SweDeliver family. Throughout the year, our management team embarked on a comprehensive round trip, engaging with the majority of our industry partners at their respective sites. The outlook for SweDeliver is optimistic, underscored by the success of our PhD students' half-time seminars this autumn term. Their accomplishments serve as a testament to the dedication and excellence within our community.

As we approach 2024, we eagerly anticipate continuing this exciting journey together. Until then, we extend warm wishes for a peaceful and relaxing holiday season spent with family and friends!

Alexandra TelekiAlexandra Teleki
Center co-Director, SweDeliver
Associate Professor, Uppsala University

Currently at SweDeliver

Last modified: 2022-11-16